Nanoporous diopside modulates biocompatibility, degradability and osteogenesis of bioactive scaffolds of gliadin-based composites for new bone formation
Authors Ba Z, Chen Z, Huang Y, Feng D, Zhao Q, Zhu J, Wu D
Received 11 January 2018
Accepted for publication 26 April 2018
Published 4 July 2018 Volume 2018:13 Pages 3883—3896
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 7
Editor who approved publication: Dr Lei Yang
Zhaoyu Ba,1,* Zhaoxiong Chen,1,* Yufeng Huang,1,* Du Feng,2 Qinghui Zhao,3 Jianguang Zhu,1 Desheng Wu1
1Department of Spinal Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China; 2Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer Hospital, Institute of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China; 3Biobank, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
*These authors contributed equally to this work
Introduction: It is predicted that with increased life expectancy in the whole world, there will be a greater demand for synthetic biomedical materials to repair or regenerate lost, injured or diseased tissues. Natural polymers, as biomedical materials, have been widely applied in the field of regenerative medicine.
Materials and methods: By incorporation of nanoporous diopside bioglass (nDPB) into gliadin (GL) matrix, macro–nanoporous scaffolds of nDPB/GL composites (DGC) were fabricated by method of solution compressing and particles leaching.
Results: The results revealed that the DGC scaffolds possessed well-interconnected macropores of 200–500 µm and nanopores of 4 nm, and the porosity and degradability of DGC scaffolds remarkably increased with the increase in nDPB content. In addition, in vitro cell experiments revealed that the adhesion and growth of MC3T3-E1 cells on DGC scaffolds were significantly promoted, which depended on nDPB content. Moreover, the results of histological evaluations confirmed that the osteogenic properties and degradability of DGC scaffolds in vivo significantly improved, which were nDPB content dependent. Furthermore, the results of immunohistochemical analysis demonstrated that, with the increase in nDPB content, the type I collagen expression in DGC scaffolds in vivo obviously enhanced, indicating excellent osteogenesis.
Discussion and conclusion: The results demonstrated that the DGC scaffolds containing 30 wt% nDPB (30nDGC) exhibited good biocompatibility and new bone formation ability, which might have a great potential for applications in bone regeneration.
Keywords: nanoporous diopside bioglass, gliadin, macro-nanoporous, MC3T3-E1, osteogenesis
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]